BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18367861)

  • 1. Hepatic myelopathy as a presenting neurological complication in patients with cirrhosis and spontaneous splenorenal shunt.
    Koo JE; Lim YS; Myung SJ; Suh KS; Kim KM; Lee HC; Chung YH; Lee YS; Suh DJ
    Korean J Hepatol; 2008 Mar; 14(1):89-96. PubMed ID: 18367861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic myelopathy after splenorenal shunting: report of one case and review of the literature.
    Yengue P; Adler M; Bouhdid H; Mavroudakis N; Gelin M; Bourgeois N
    Acta Gastroenterol Belg; 2001; 64(2):231-3. PubMed ID: 11475143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic myelopathy neurological complication of chronic liver disease: two case reports.
    Mhiri M; Ben Abdelwahed M; Dhiflaoui MA; Ben Dhia R; Gouta N; Jemni I; Baklouti R; Zakhama M; Gueddiche A; Loghmari MH; Ben Chaabene N; Safer L; Frih-Ayed M
    J Med Case Rep; 2024 Jun; 18(1):281. PubMed ID: 38880918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic myelopathy with spastic paraparesis: report of two cases and review of the literature.
    Ben Amor S; Saied MZ; Harzallah MS; Benammou S
    Eur Spine J; 2014 May; 23 Suppl 2():167-71. PubMed ID: 23728397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic myelopathy with spastic paraparesis.
    Utku U; Asil T; Balci K; Uzunca I; Celik Y
    Clin Neurol Neurosurg; 2005 Oct; 107(6):514-6. PubMed ID: 16202825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting.
    Conn HO; Rössle M; Levy L; Glocker FX
    Scand J Gastroenterol; 2006 May; 41(5):619-25. PubMed ID: 16638707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic myelopathy: a rare complication following extrahepatic portal vein occlusion and lienorenal shunt.
    Panicker J; Sinha S; Taly AB; Ravishankar S; Arunodaya GR
    Neurol India; 2006 Sep; 54(3):298-300. PubMed ID: 16936395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial splenic artery embolization for severe hepatic myelopathy in cirrhosis.
    Philips CA; Kumar L; Augustine P
    Hepatology; 2018 Mar; 67(3):1169-1171. PubMed ID: 29059463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spastic paraparesis associated with advanced liver cirrhosis: a condition obscure in terms of treatment and prognosis.
    Kaur J; Jesrani G; Gupta M; Lehl SS
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32513765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of findings of spontaneous splenorenal shunt in color Doppler sonography with multislice CT scan (64 slices) in liver transplant candidates.
    Bagheri M; Hajati A; Hosseini M; Ostad SP
    Eur J Radiol; 2012 Sep; 81(9):2027-36. PubMed ID: 21741785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic myelopathy: an unusual neurological complication of chronic liver disease presenting as quadriparesis.
    Kori P; Sahu R; Jaiswal A; Shukla R
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23749858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation improves hepatic myelopathy: evidence by three cases.
    Weissenborn K; Tietge UJ; Bokemeyer M; Mohammadi B; Bode U; Manns MP; Caselitz M
    Gastroenterology; 2003 Feb; 124(2):346-51. PubMed ID: 12557140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital intrahepatic portosystemic venous shunt presenting with paraparesis as the initial symptom.
    Torigoe M; Maeshima K; Takeshita Y
    Intern Med; 2013; 52(21):2439-42. PubMed ID: 24190148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal cord involvement in patients with cirrhosis.
    Nardone R; Höller Y; Storti M; Lochner P; Tezzon F; Golaszewski S; Brigo F; Trinka E
    World J Gastroenterol; 2014 Mar; 20(10):2578-85. PubMed ID: 24627593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large spontaneous splenorenal shunt in a patient with liver cirrhosis and uncomplicated portal hypertension.
    Iannello S; Libertini L; Martini R; Spina S; Busacca G; Ricciardi N; Andreozzi G; Belfiore F
    Dig Dis; 1999; 17(4):248-55. PubMed ID: 10754366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic encephalopathy secondary to a splenorenal shunt that manifested a long time after a liver transplantation.
    Tomás Pujante P; Jiménez Sánchez AF; Iglesias Jorquera E; Pons Miñano JA
    Rev Esp Enferm Dig; 2018 Jun; 110(6):400-401. PubMed ID: 29685040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?
    Pinarbasi B; Kaymakoglu S; Matur Z; Akyuz F; Demir K; Besisik F; Ozdil S; Boztas G; Cakaloglu Y; Mungan Z; Okten A
    J Clin Gastroenterol; 2009 Feb; 43(2):176-81. PubMed ID: 18698265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portosystemic myelopathy: a rare neurological presentation of portosystemic shunts.
    Rao PK; Sheth KA; Nadig R; Patil M; Channagiri AK
    J Clin Exp Hepatol; 2012 Dec; 2(4):393-5. PubMed ID: 25755460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic myelopathy: an unusual neurological complication of advanced hepatic disease.
    Sobukawa E; Sakimura K; Hoshino S; Hoshino M; Miyoshi K
    Intern Med; 1994 Nov; 33(11):718-22. PubMed ID: 7849390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spontaneous portasystemic shunt in liver cirrhosis: imaging with color-coded duplex ultrasonography].
    Riehl J; Bongartz D; Nguyen H; Sieberth HG
    Ultraschall Med; 1997 Dec; 18(6):272-6. PubMed ID: 9491495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.